Diagnosis, treatment and transmission of rifampicin-resistant TB in the Netherlands, 2010-2019

New tools for diagnosis and treatment of rifampicin-resistant (RR-) and multidrug-resistant (MDR-) TB have become available in the last decade, including better tests confirming transmission. To analyse transmission risks of MDR/RR-TB in the Netherlands. Analysis of national data of patients with MD...

Celý popis

Podrobná bibliografia

Vydané v:	The international journal of tuberculosis and lung disease Ročník 27; číslo 6; s. 471
Hlavní autori:	de Vries, G, Akkerman, O, Boeree, M, van Hest, R, Kamst, M, de Lange, W, Magis-Escurra, C, Meijer, W, van Soolingen, D
Médium:	Journal Article
Jazyk:	English
Vydavateľské údaje:	France 01.06.2023
Predmet:	Antitubercular Agents - pharmacology Female Humans Mycobacterium tuberculosis - genetics Netherlands - epidemiology Rifampin - pharmacology Rifampin - therapeutic use Tuberculosis, Multidrug-Resistant - diagnosis Tuberculosis, Multidrug-Resistant - drug therapy Tuberculosis, Multidrug-Resistant - epidemiology Tuberculosis, Pulmonary - diagnosis Netherlands
ISSN:	1815-7920, 1815-7920
On-line prístup:	Zistit podrobnosti o prístupe
Tagy:	Pridať tag Žiadne tagy, Buďte prvý, kto otaguje tento záznam!